Birendra Chaurasiya

Birendra Chaurasiya

Auto-generated profile, based on publicly available information

Birendra Chaurasiya

Department of Pediatrics, Critical Care Division, Stanley Manne Children’s Research Institute, Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
BDBuyankhishig Dorjsuren
Buyankhishig Dorjsuren
BCBirendra Chaurasiya
Birendra Chaurasiya
ZYZixuan Ye
Zixuan Ye
YLYanyan Liu
Yanyan Liu
WLWei Li
Wei Li
Yan ShenYan Shen
Yan Shen
Background: One major limitation of cancer chemotherapy is a failure to specifically target a tumor, potentially leading to side effects such as systemic cytotoxicity. In this case, we have generated a cancer cell-targeting nanoparticle-liposome drug delivery system that can be activated by near-infrared laser light to enable local photo-thermal therapy and the release of chemotherapeutic agents, which could achieve combined therapeutic efficiency. Methods: To exploit the magnetic potential of iron oxide, we prepared and characterized citric acid-coated iron oxide magnetic nanoparticles (CMNPs) and encapsulated them into thermo-sensitive liposomes (TSLs). The chemotherapeutic drug, doxorubicin (DOX), was then loaded into the CMNP-TSLs, which were coated with an antibody against the epidermal growth factor receptor (EGFR), cetuximab (CET), to target EGFR-expressing breast cancer cells in vitro and in vivo studies in mouse model. Results: The resulting CET-DOX-CMNP–TSLs were stable with an average diameter of approximately 120 nm. First, the uptake of TSLs into breast cancer cells increased by the addition of the CET coating. Next, the viability of breast cancer cells treated with CET-CMNP-TSLs and CET-DOX-CMNP-TSLs was reduced by the addition of photo-thermal therapy using near-infrared (NIR) laser irradiation. What is more, the viability of breast cancer cells treated with CMNP-TSLs plus NIR was reduced by the addition of DOX to the CMNP-TSLs. Finally, photo-thermal therapy studies on tumor-bearing mice subjected to NIR laser irradiation showed that treatment with CMNP-TSLs or CET-CMNP-TSLs led to an increase in tumor surface temperature to 44.7°C and 48.7°C, respectively, compared with saline-treated mice body temperature ie, 35.2°C. Further, the hemolysis study shows that these nanocarriers are safe for systemic delivery. Conclusion: Our studies revealed that a combined therapy of photo-thermal therapy and targeted chemotherapy in thermo-sensitive nano-carriers represents a promising therapeutic strategy against breast cancer.

1 April 2018 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
LHLiping Huang
Liping Huang
BCBirendra Chaurasiya
Birendra Chaurasiya
DWDawei Wu
Dawei Wu
HWHuimin Wang
Huimin Wang
YDYunai Du
Yunai Du
CSChunmeng Sun
Chunmeng Sun

1 April 2018 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
JXJunping Xia
Junping Xia
YDYunai Du
Yunai Du
LHLiping Huang
Liping Huang
BCBirendra Chaurasiya
Birendra Chaurasiya
JTJiasheng Tu
Jiasheng Tu
CSChunmeng Sun
Chunmeng Sun

1 January 2019 in Drug Delivery
Verified
Journal Article
Open access
YMYujuan Mao
Yujuan Mao
XCXiaolan Chen
Xiaolan Chen
BXBohui Xu
Bohui Xu
YSYan Shen
Yan Shen
ZYZixuan Ye
Zixuan Ye
DCDaquan Chen
Daquan Chen
Nanoemulgels are composed of O/W nanoemulsion and hydrogels and are considered as ideal carriers for the transdermal drug delivery because these have high affinity to load hydrophobic drugs. The stable formulation of eprinomectin (EPR) is very challenging because of it is high hydrophobic nature. In this work, we have prepared EPR loaded nanoemulgel for the treatment of endo- and ectoparasites. The surface morphology of optimized formulations was characterized by scanning electron microscopy. Additionally, skin permeability and irritation tests were conducted for in vitro safety and in vivo skin retention and pearmeation test of EPR nanoemulgel were conducted for efficacy study. Obtained results indicated that the optimized formulation had good shear-thinning behavior, bioadhesiveness properties, and are nanosized droplets with porous internal structure, which are required for topical application. Furthermore, this formulation has showed good skin permeability in comparison to suspension and has no skin irritating property. Overall, the obtained results proved that nanoemulgel is a promising carrier for transdermal drug delivery and EPR nanoemulgel is a promising formulation for the treatment of endo- and ectoparasites.

1 February 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
IMImran Shair Mohammad
Imran Shair Mohammad
CTChao Teng
Chao Teng
BCBirendra Chaurasiya
Birendra Chaurasiya
LYLifang Yin
Lifang Yin
CWChunyong Wu
Chunyong Wu
Wei HeWei He
Wei He

3 December 2018 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
YTYu Tian
Yu Tian
GMGujie Mi
Gujie Mi
QCQian Chen
Qian Chen
BCBirendra Chaurasiya
Birendra Chaurasiya
YLYanan Li
Yanan Li
YSYan Shen
Yan Shen